Plasma vemurafenib exposure and pre-treatment hepatocyte growth factor level are two factors contributing to the early peripheral lymphocytes depletion in BRAF-mutated melanoma patients
Titel:
Plasma vemurafenib exposure and pre-treatment hepatocyte growth factor level are two factors contributing to the early peripheral lymphocytes depletion in BRAF-mutated melanoma patients
Auteur:
Puszkiel, Alicja White-Koning, Mélanie Dupin, Nicolas Kramkimel, Nora Thomas-Schoemann, Audrey Noé, Gaëlle Chapuis, Nicolas Vidal, Michel Goldwasser, François Chatelut, Etienne Blanchet, Benoit